Dr. Hershberger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
502 E New Haven Ave
Melbourne, FL 32901Phone+1 407-834-7776Fax+1 407-834-0973
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Ophthalmology, 2000 - 2003
Christ HospitalInternship, Internal Medicine, 1999 - 2000
University of Cincinnati College of MedicineClass of 1999
Certifications & Licensure
FL State Medical License 2004 - 2026
OH State Medical License 1999 - 2006- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration.Sunil Patel, Philip P Storey, Mark R Barakat, Vrinda Hershberger, William Z Bridges Jr
Ophthalmology Science. 2024-04-09 - 15 citationsInhibition of Complement C3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results.Charles C. Wykoff, Vrinda S. Hershberger, David A Eichenbaum, Erin C. Henry, Husam Younis
American Journal of Ophthalmology. 2021-09-09 - 15 citationsPhase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration.Arshad M. Khanani, Vrinda S. Hershberger, Dante J. Pieramici, Rahul N. Khurana, Flavia Brunstein
American Journal of Ophthalmology. 2021-06-29
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
